Brain-derived neurotrophic factor and neurotrophin-3 mRNAs are expressed in ventral midbrain regions containing dopaminergic neurons

https://doi.org/10.1016/1044-7431(92)90009-QGet rights and content

Abstract

Recent evidence suggests that brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) enhance the survival of ventral mesencephalic dopaminergic neurons. In this study, cellular distributions of mRNAs for the nerve growth factor (NGF) family of neurotrophins (NGF, BDNF, and NT-3) and the catecholamine biosynthetic enzyme tyrosine hydroxylase (TH) were evaluated in the ventral mesencephalon of adult rat to determine if the neurotrophins are synthesized in regions of the responsive dopaminergic cells. Messenger RNAs were localized by in situ hybridization of 35S-labeled cRNA probes and emulsion autoradiography. Neurotrophin-3 cRNA labeled neurons in the ventral tegmental area, medial substantia nigra pars compacta, and retrorubral field. The distributions of NT-3 mRNA-containing and TH mRNA-containing neurons corresponded very well in these areas. Hybridization of the BDNF cRNA labeled scattered cells in corresponding fields of TH mRNA-containing neurons in both the ventral tegmental area and the medial substantia nigra pars compacta but, in contrast to NT-3 cRNA, labeled fewer cells in these areas. Somata containing BDNF mRNA were also present in surrounding regions, including the interfascicular and interpeduncular nuclei, the supramammillary region, the periaqueductal grey matter, and fields dorsal to the lateral substantia nigra. Hybridization of NGF cRNA was not observed in the ventral mesencephalon. These results demonstrate that mRNAs for NT-3 and BDNF are expressed by neurons in both the substantia nigra and ventral tegmental area of adult rat and suggest that trophic support for the dopaminergic neurons in these areas may arise from local synthesis. Moreover, these results raise the possibility that perturbations in local neurotrophin synthesis might contribute to dopamine-related disorders including Parkinson's disease and schizophrenia.

References (46)

  • J. Leibrock et al.

    Molecular cloning and expression of brain-derived neurotrophic factor

    Nature

    (1990)
  • A. Hohn et al.

    Identification and characterization of a novel member of the nerve growth factor/brain derived neurotrophic factor family

    Nature

    (1990)
  • P.C. Maisonpierre et al.

    Neurotrophin-3: A neurotrophic factor related to NGF and BDNF

    Science

    (1990)
  • P. Ernfors et al.

    Molecular cloning and neurotrophic activities of a protein with structural similarities to ,B-nerve growth factor: Developmental and topographical expression in the brain

  • H.S. Phillips et al.

    Widespread expression of BDNF but not NT3 by target areas of basal forebrain cholinergic neurons

    Science

    (1990)
  • F. Hefti

    Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections

    J. Neurosci.

    (1986)
  • L.R. Williams et al.

    Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection

  • L.F. Kromer

    Nerve growth factor treatment after brain injury prevents neuronal death

    Science

    (1987)
  • F. Hefti et al.

    Nerve growth factor and Alzheimer's disease

    Ann. Neurol.

    (1986)
  • M.H. Tuszynski et al.

    Nerve growth factor infusion in the primate brain reduces lesion-induced cholinergic neuronal degeneration

    J. Neurosci.

    (1990)
  • I. Strömberg et al.

    Rescue of basal forebrain cholinergic neurons after implantation of genetically modified cells producing recombinant NGF

    J. Neurosci. Res.

    (1990)
  • B. Knüsel et al.

    Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neuro trophic factor but not neurotrophin 3

  • C. Hyman et al.

    BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra

    Nature

    (1991)
  • Cited by (0)

    View full text